Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2026 06:49 ET | Source: Hagens Berman Sobol Shapiro LLP

TLX FINAL DEADLINE ALERT: Hagens Berman Alerts Telix Pharm. (TLX) Investors of Today’s Lead Plaintiff Deadline in Securities Class Action

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
January 07, 2026 18:02 ET | Source: Hagens Berman Sobol Shapiro LLP

Telix (TLX) 2-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
January 05, 2026 09:09 ET | Source: Hagens Berman Sobol Shapiro LLP

Telix (TLX) 4-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
January 04, 2026 12:00 ET | Source: Hagens Berman Sobol Shapiro LLP

TLX 5-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

SAN FRANCISCO, Jan. 04, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline...
January 02, 2026 14:24 ET | Source: Hagens Berman Sobol Shapiro LLP

TLX 7-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

SAN FRANCISCO, Jan. 02, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline...
December 31, 2025 14:01 ET | Source: Hagens Berman Sobol Shapiro LLP

TLX CLASS ACTION DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

SAN FRANCISCO, Dec. 31, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline...
December 29, 2025 16:48 ET | Source: Hagens Berman Sobol Shapiro LLP

TLX 11-DAY DEADLINE ALERT: Hagens Berman Urges Telix (TLX) Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
December 25, 2025 12:00 ET | Source: Hagens Berman Sobol Shapiro LLP

TLX CLASS ACTION DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
December 18, 2025 10:50 ET | Source: Hagens Berman Sobol Shapiro LLP

21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
December 16, 2025 18:54 ET | Source: Hagens Berman Sobol Shapiro LLP

21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.